Garenoxacin

CAS: 194804-75-6

Ref. 3D-FG23648

Produktinformation

• Name: Garenoxacin
• Synonyme: 1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acidGanefl oxacin, (R)-1-Cyclopropyl-8-(difluoromethoxy)-7-(1-methylisoindolin-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid methanesulfonate (1:1), 3-Quinolinecarboxylic acid, 1-cyclopropyl-8-(difluoromethoxy)-7-(2,3-dihydro-1-methyl-1H-isoindol-5-yl)-1,4-dihydro-4-oxo-, (+)-, 3-Quinolinecarboxylic acid, 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-, Ganefloxacin, Garenfloxacin, Garenoxacin Hbr, T 3811

Beschreibung

Garenoxacin is a non-steroidal anti-inflammatory drug (NSAID) that has been shown to inhibit the production of inflammatory substances. It is active against gram-positive bacteria but not against gram-negative species. Garenoxacin inhibits the growth of wild type and resistant mutants of human polymorphonuclear leukocytes and tissue infection isolates, both of which are sensitive to other NSAIDs. Clinical studies have shown that garenoxacin has antibacterial efficacy in vitro and in vivo with minimal toxicity. Drug interactions are possible, as garenoxacin inhibits cytochrome P450 enzymes and increases the blood concentration of some drugs such as warfarin, phenytoin, or carbamazepine.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 426.41 g/mol
• Formel: C₂₃H₂₀F₂N₂O₄
• Reinheit: Min. 95%
• Farbe/Form: White Powder